Servier to Acquire Day One Biopharmaceuticals for $2.5 Billion to Expand Cancer Drug Portfolio
French pharmaceutical company Servier has announced that it will acquire U.S.-based biotech firm Day One Biopharmaceuticals in a…
French pharmaceutical company Servier has announced that it will acquire U.S.-based biotech firm Day One Biopharmaceuticals in a…